MANNATECH INC Research and Development Expense
MANNATECH INC (MTEX) reported Research and Development Expense of $800.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-15
- MANNATECH INC research and development expense for fiscal 2025 was $800.00K, a 14.29% increase from fiscal 2024.
- MANNATECH INC research and development expense for fiscal 2024 was $700.00K, a 12.50% decline from fiscal 2023.
- MANNATECH INC research and development expense for fiscal 2023 was $800.00K, a 20.00% decline from fiscal 2022.
- MANNATECH INC research and development expense for fiscal 2022 was $1.00M, a 16.67% decline from fiscal 2021.
| Period end | Research and Development Expense 12 month |
|---|---|
| 2025-12-31 | $800.00K 10-K · filed 2026-04-15 |
| 2024-12-31 | $700.00K 10-K · filed 2026-04-15 |
| 2023-12-31 | $800.00K 10-K · filed 2025-03-26 |
| 2022-12-31 | $1.00M 10-K · filed 2024-03-28 |
| 2021-12-31 | $1.20M 10-K · filed 2023-03-17 |
| 2020-12-31 | $800.00K 10-K · filed 2022-03-15 |
| 2019-12-31 | $1.10M 10-K · filed 2021-03-19 |
| 2018-12-31 | $1.00M 10-K · filed 2020-03-26 |
| 2017-12-31 | $1.20M 10-K · filed 2019-03-11 |
| 2016-12-31 | $1.40M 10-K · filed 2018-03-26 |
| 2015-12-31 | $1.70M 10-K · filed 2017-03-14 |
| 2014-12-31 | $1.60M 10-K · filed 2016-03-15 |
| 2013-12-31 | $1.60M 10-K · filed 2015-03-10 |
| 2012-12-31 | $1.90M 10-K · filed 2014-03-18 |
| 2011-12-31 | $3.00M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |